Skip to main content

Life Science Startups

Updated November 2026

Companies in the life science sector developing innovative solutions and technologies.

Explore 1,587 recently funded life science companies with verified founder contact information and fundraising data.

Total Companies
1,587
Total Funding
$805.0M
Avg Funding
$32.2M
Global Reach
8
countries

Top Cities for Life Science

Cambridge
Surrey
Albuquerque
London
Marblehead
Hayward

Recently Funded Companies

Export
Cambridge, United States

Garuda Therapeutics develops off-the-shelf hematopoietic stem cell therapies to treat severe and life-threatening diseases.

$50.0M raised
Mar 2025

Founder Contacts

41,000+ verified contacts

Surrey, Canada

HealthTech Connex focuses on technology-based innovations for health improvements and outcomes.

$2.6M raised
Mar 2025

Founder Contacts

41,000+ verified contacts

Albuquerque, United States

Terra Vera is an agriculture technology provider that enables customers to grow crops that are better able to yield their full potential.

$90K raised
Mar 2025

Founder Contacts

41,000+ verified contacts

London, United Kingdom

Lifelancer is a global platform for talent hiring in Life Sciences, Pharma, Healthtech & IT

$236K raised
Mar 2025

Founder Contacts

41,000+ verified contacts

Marblehead, United States

Morphoceuticals is a biotechnology platform establishing a basis for limb regeneration and the discovery of regenerative interventions.

Feb 2025

Founder Contacts

41,000+ verified contacts

London, United Kingdom

Ignota Labs recognizes that safety errors during the drug discovery process.

$6.9M raised
Feb 2025

Founder Contacts

41,000+ verified contacts

Hayward, United States

Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.

$350.7M raised
Feb 2025

Founder Contacts

41,000+ verified contacts

Amsterdam, The Netherlands

EvidenceHunt is an AI-powered medical research platform that transforms how professionals find, analyze, and process medical evidence.

$1.3M raised
Feb 2025

Founder Contacts

41,000+ verified contacts

Exton, United States

Castle Creek Biosciences is focused on developing commercializing novel, personalized gene therapies for rare skin disorders.

$75.0M raised
Feb 2025

Founder Contacts

41,000+ verified contacts

Toronto, Canada

Paradox Immunotherapeutics is a pharmaceutical company that develops treatments for patients suffering from rare amyloid diseases.

$10.0M raised
Feb 2025

Founder Contacts

41,000+ verified contacts

Newport Beach, United States

Avandra a biggest federated network for clinical data and medical imaging.

$17.8M raised
Feb 2025

Founder Contacts

41,000+ verified contacts

Watertown, United States

EnPlusOne Biosciences provides innovative solutions for emerging RNA therapeutics.

$10.0M raised
Feb 2025

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Perceive Pharma operates as a pharmaceutical company.

$15.0M raised
Feb 2025

Founder Contacts

41,000+ verified contacts

Vilnius, Lithuania

Atrandi Biosciences is a Lithuanian biotech startup that aims to commercialize droplet microfluidics technology.

$25.0M raised
Feb 2025

Founder Contacts

41,000+ verified contacts

Champaign, United States

Epivara provides a single-injection alternative to spay and neuter surgery.

$2.0M raised
Feb 2025

Founder Contacts

41,000+ verified contacts

Boston, United States

Bambusa Therapeutics operates as biotechnology company.

$90.0M raised
Feb 2025

Founder Contacts

41,000+ verified contacts

London, United Kingdom

We are making biology programmable to transform health and sustainability for the benefit of all.

$40.0M raised
Feb 2025

Founder Contacts

41,000+ verified contacts

Blue Bell, United States

ThirdLaw Molecular pioneers revolutionary SpiroligomerN molecules for safer, more targeted, effective disease treatment.

$1.5M raised
Feb 2025

Founder Contacts

41,000+ verified contacts

Hanover, Germany

Phaeosynt is a biotechnology company that produces animal-free antibodies using microalgae and diatomaceous earth.

$1.8M raised
Feb 2025

Founder Contacts

41,000+ verified contacts

Kelowna, Canada

MYND Life Sciences is a life sciences company focused on novel psychedelic drug development and pharmaceuticals.

$1.6M raised
Feb 2025

Founder Contacts

41,000+ verified contacts

Natick, United States

Stellaromics is a biotechnology company that specializes in 3D in situ multi-omic analysis technology.

$80.0M raised
Feb 2025

Founder Contacts

41,000+ verified contacts

Tucker, United States

NovAb is a biotechnology company developing therapeutic drugs, diagnostic reagents, and biomedical research reagents.

$460K raised
Feb 2025

Founder Contacts

41,000+ verified contacts

Madrid, Spain

Amadix is a biotechnology company focused on the development and commercialization of diagnostic tools for personalized oncology treatment.

$15.5M raised
Feb 2025

Founder Contacts

41,000+ verified contacts

Le Kremlin-bicêtre, France

DNA Script is a disruptive DNA synthesis company harnessing biology to accelerate breakthroughs in life science and human health.

$4.7M raised
Feb 2025

Founder Contacts

41,000+ verified contacts

Salt Lake City, United States

iVeena develops ocular drug products that eliminate the need for eye drop application and painful injections.

$3.0M raised
Feb 2025

Founder Contacts

41,000+ verified contacts

Showing 651 to 675 of 1,587 companies

About the Life Science Startup Ecosystem

The life science sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Life Science

Life Science companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The life science sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Life Science Funding Breakdown

Here is how funding is distributed among the 1,587 life science companies tracked in the VCBacked database.

Average Funding
$32.2M
Total Funding Tracked
$805.0M
Countries Represented
8

Distribution by Funding Stage

Other25 companies

Top Cities for Life Science

1.London
3 companies$47.1M
2.Cambridge
1 companies$50.0M
3.Surrey
1 companies$2.6M
4.Albuquerque
1 companies$90K
5.Marblehead
1 companiesUndisclosed

Related Industries

Companies in the life science sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Life Science Startups?

Perfect for: B2B sales teams targeting life science companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked